|
||
J. Exp. Med.,
Volume 186, Number 9, November 3, 1997 1575-1583
By


From the * Wellcome Trust Immunology Unit, Department of Medicine, University of Cambridge
School of Clinical Medicine, Cambridge CB2 2SP, United Kingdom; and We wish to identify developmental changes in germinal center B cells that may contribute to
their rapid growth. SHP-1 is an SH2 domain-containing phosphotyrosine phosphatase that
negatively regulates activation of B cells and other cells of hematopoietic lineages. We have
found that in all 13 EBV-negative and 11 EBV-positive Burkitt lymphomas with a nonlymphoblastoid phenotype, the mean concentration of SHP-1 was reduced to 5% of that of normal
B and T cells. The possibility that this diminished expression of SHP-1 was related to the germinal center phenotype of Burkitt lymphomas was supported by the low to absent immunofluorescent staining for SHP-1 in germinal centers, and by the inverse relationship between the
concentration of SHP-1 and the expression of the germinal center marker CD38 on purified
tonsillar B cells. In CD38-high B cells, SHP-1 concentration was 20% of that of mantle zone B cells from the same donor. This reduction in SHP-1 is comparable to that of cells from motheaten viable mev/mev mice in which there is dysregulated, spontaneous signaling by cytokine
and antigen receptors. Therefore, germinal center B cells may have a developmentally regulated, low threshold for cellular activation.
Department of Medicine,
University of Wales, College of Medicine, Heath Park, Cardiff CF4 4XX, United Kingdom
This article has been cited by other articles:
| TABLE OF CONTENTS |
|